DBP-UiO |
Hf |
H2DBP |
High PS loading; more ROS production; enhanced ISCs |
[47] |
DBC-UiO |
Hf |
H2DBC |
High PS loading; high stability; high porosity; enhanced ISCs and more efficient 1O2 generation |
[52] |
Hf-TCPP |
Hf |
TCPP |
High PS loding; large Brunauer−Emmett−Teller (BET) surface; RT sensitizer (Hf); |
[143,145] |
PCN-224 |
Zr |
|
Improved chemical stability; |
[49,54,88] |
Zr-TBB |
Zr |
H4TBB |
Achieve excellent photostability; perform type I and type II PDT; produce 4 types of ROS |
[54] |
PCN-229 |
Zr |
H4TCP-2 |
Higher porosity and BET surface area |
[76] |
PCN-300 |
Zr |
H4TCP-3 |
Excellent stability in aqueous solution with pH ranging from 0 to 12 |
[76] |
TBP-MOF |
Zr |
H4TBP |
Higher chemical stability; red-shifted absorption bands and stronger infrared luminescence characteristics |
[90] |
UiO-PDT |
Zr |
I2-BDP |
Low dark toxicity; high cell uptake; good biocompatibility and high 1O2 production |
[98] |
UiO-68-NH2
|
Zr |
2-aminoterephthalic acid |
The amino group of the ligands provides the site for conjugate modification |
[113] |
UiO-66 |
Zn |
Purified terephthalic acid (TPA) |
Achieve nanosized porphyrin with heavy iodine atoms; achieve nanoscale; easy surface modification; high structural stability |
[98,112] |
ZIF-8 |
Zn |
2-methylimidazole |
pH-responsive property; easy to achieve nanoscale under mild synthesis conditions; good solubility in aqueous solution |
[36,48,56,110] |
ZIF-90 |
Zn |
IcaHs; 2I-Bodipy |
Avoid PS aggregation and self-quenching; low cytotoxicity; high cell permeability; good biocompatibility; pH-driven selective tumor cell uptake; mitochondrial targeting and efficient 1O2 generation |
[114] |
CuTz-1 |
Cu |
3,5-diphenyltriazole (3,5-Ph2-tzH) |
Carry oxygen, alleviate hypoxia; achieve type I PDT |
[100] |
MOF-199 |
Cu |
H3BTC |
Inert carrier; remove intracellular GSH |
[106,111] |
MOF-2 |
Cu;Al |
Meso-tetrakis (4-carboxyphenyl) porphyrin |
Decrease intracellular GSH |
[105] |
Ti-TBP |
Ti |
H4TBP |
Produce 4 types of ROS; achieve hypoxia-tolerant type I PDT and oxygen-dependent type II PDT |
[53] |
Fe-TBP |
Fe |
H4TBP |
Generate O2 through Fenton-like reaction to overcome hypoxia |
[151] |